ACE inhibitors that cross the blood-brain barrier reduce the risk by 15%-16%
Taking an ACE inhibitor that crosses the blood-brain barrier reduced the risk of being diagnosed with dementia and delayed the time to a diagnosis of dementia in people with HIV receiving care in Veterans Affairs clinics in the United States, researchers report.
The study compared people who took an ACE inhibitor that crosses the blood-brain barrier and those who took no medication or another type of medication to treat high blood pressure.
Read the full story at Aidsmap.
Source : Aidsmap
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.